Advertisement
UK markets closed

  • NIKKEI 225

    33,231.27
    -200.24 (-0.60%)
     

  • HANG SENG

    16,646.05
    -184.25 (-1.09%)
     

  • CRUDE OIL

    73.29
    +0.25 (+0.34%)
     

  • GOLD FUTURES

    2,048.20
    -41.50 (-1.99%)
     

  • DOW

    36,204.44
    -41.06 (-0.11%)
     

  • Bitcoin GBP

    33,186.41
    +1,513.69 (+4.78%)
     

  • CMC Crypto 200

    860.54
    +1.83 (+0.21%)
     

  • NASDAQ Composite

    14,185.49
    -119.54 (-0.84%)
     

  • UK FTSE All Share

    4,085.31
    -9.17 (-0.22%)
     
Investing:

Is the world’s most important asset market broken?

Regulators have proposed radical changes to how Treasuries are traded, to the dismay of investors

Ipsen SA - Monthly information relative to the total number of voting rights and shares composing the share capital - April 2023

Ipsen Pharma
·1-min read
Ipsen Pharma
Ipsen Pharma

  

Monthly information relative to the total number of voting rights
and shares composing the share capital

(in accordance with Article L.233-8 II of the French Commercial Code and
Article 223-16 of the General Regulation of the Autorité des Marchés Financiers)

Market: Euronext Paris
ISIN Code: FR 0010259150
LEI: 549300M6SGDPB4Z94P11

Date

Total number of shares composing the share capital

Total number of voting rights (1)

30 April 2023

83,814,526

Gross total* of voting rights: 132,089,350

Net total** of voting rights: 130,926,938

(1) Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10).

* Gross total = total number of voting rights attached to the total number of shares, including the number of shares which benefit of double voting rights and the number of treasury shares. The « Gross total » is used as a basis for the calculation of threshold crossings.

** Net total = total number of voting rights attached to the total number of shares – shares without voting rights.

Attachment